Polygenic Score (PGS) ID: PGS001354

Predicted Trait
Reported Trait Thyroid cancer
Mapped Trait(s) thyroid carcinoma (EFO_0002892)
Released in PGS Catalog: Nov. 4, 2021
Download Score FTP directory
Terms and Licenses
PGS obtained from the Catalog should be cited appropriately, and used in accordance with any licensing restrictions set by the authors. See EBI Terms of Use (https://www.ebi.ac.uk/about/terms-of-use/) for additional details.

Score Details

Score Construction
PGS Name PRS12_TC
Development Method
Name Variants significantly associated with thyroid cancer
Parameters Associations in European ancestry
Variants
Original Genome Build NR
Number of Variants 12
Effect Weight Type NR
PGS Source
PGS Catalog Publication (PGP) ID PGP000251
Citation (link to publication) Song N et al. Cancer Epidemiol Biomarkers Prev (2021)
Ancestry Distribution
Source of Variant
Associations (GWAS)
European: 100%
290,551 individuals (100%)
PGS Evaluation
European: 100%
2 Sample Sets

Development Samples

Source of Variant Associations (GWAS)
Study Identifiers Sample Numbers Sample Ancestry Cohort(s)
GWAS Catalog: GCST004144
Europe PMC: 28195142
290,551 individuals European ICR, NBS, ODZH, RUNMC, deCODE

Performance Metrics

Disclaimer: The performance metrics are displayed as reported by the source studies. It is important to note that metrics are not necessarily comparable with each other. For example, metrics depend on the sample characteristics (described by the PGS Catalog Sample Set [PSS] ID), phenotyping, and statistical modelling. Please refer to the source publication for additional guidance on performance.

PGS Performance
Metric ID (PPM)
PGS Sample Set ID
(PSS)
Performance Source Trait PGS Effect Sizes
(per SD change)
Classification Metrics Other Metrics Covariates Included in the Model PGS Performance:
Other Relevant Information
PPM005178 PSS003603|
European Ancestry|
2,370 individuals
PGP000251 |
Song N et al. Cancer Epidemiol Biomarkers Prev (2021)
Reported Trait: Subsequent thyroid cancer in childhood cancer survivors Relative Rate (RR): 1.57 [1.24, 1.98] Attained age modeled by restricted cubic splines
PPM005179 PSS003603|
European Ancestry|
2,370 individuals
PGP000251 |
Song N et al. Cancer Epidemiol Biomarkers Prev (2021)
Reported Trait: Subsequent thyroid cancer in childhood cancer survivors who had received neck radiotherapy Relative Rate (RR): 1.68 [1.29, 2.18] Attained age modeled by restricted cubic splines
PPM005180 PSS003602|
European Ancestry|
6,416 individuals
PGP000251 |
Song N et al. Cancer Epidemiol Biomarkers Prev (2021)
Reported Trait: Subsequent thyroid cancer in childhood cancer survivors Relative Rate (RR): 1.52 [1.25, 1.83] Attained age modeled by restricted cubic splines
PPM005181 PSS003602|
European Ancestry|
6,416 individuals
PGP000251 |
Song N et al. Cancer Epidemiol Biomarkers Prev (2021)
Reported Trait: Subsequent thyroid cancer in childhood cancer survivors who had received neck radiotherapy Relative Rate (RR): 1.42 [1.09, 1.85] Attained age modeled by restricted cubic splines
PPM005182 PSS003602|
European Ancestry|
6,416 individuals
PGP000251 |
Song N et al. Cancer Epidemiol Biomarkers Prev (2021)
Reported Trait: Subsequent thyroid cancer in childhood cancer survivors who had not received neck radiotherapy Relative Rate (RR): 1.66 [1.26, 2.2] Attained age modeled by restricted cubic splines
PPM005183 PSS003603|
European Ancestry|
2,370 individuals
PGP000251 |
Song N et al. Cancer Epidemiol Biomarkers Prev (2021)
Reported Trait: Subsequent thyroid cancer in childhood cancer survivors aged 40 AUROC: 0.83
C-index: 0.842
Clincial model (age at diagnosis, attained age modeled by restricted cubic splines, sex, combined treatment group)
PPM005184 PSS003602|
European Ancestry|
6,416 individuals
PGP000251 |
Song N et al. Cancer Epidemiol Biomarkers Prev (2021)
Reported Trait: Subsequent thyroid cancer in childhood cancer survivors aged 40 AUROC: 0.73
C-index: 0.73
Clincial model (age at diagnosis, attained age modeled by restricted cubic splines, sex, combined treatment group)
PPM005185 PSS003603|
European Ancestry|
2,370 individuals
PGP000251 |
Song N et al. Cancer Epidemiol Biomarkers Prev (2021)
Reported Trait: Subsequent thyroid cancer in childhood cancer survivors aged 50 AUROC: 0.82
C-index: 0.834
Clincial model (age at diagnosis, attained age modeled by restricted cubic splines, sex, combined treatment group)
PPM005186 PSS003602|
European Ancestry|
6,416 individuals
PGP000251 |
Song N et al. Cancer Epidemiol Biomarkers Prev (2021)
Reported Trait: Subsequent thyroid cancer in childhood cancer survivors aged 50 AUROC: 0.72
C-index: 0.727
Clincial model (age at diagnosis, attained age modeled by restricted cubic splines, sex, combined treatment group)

Evaluated Samples

PGS Sample Set ID
(PSS)
Phenotype Definitions and Methods Participant Follow-up Time Sample Numbers Age of Study Participants Sample Ancestry Additional Ancestry Description Cohort(s) Additional Sample/Cohort Information
PSS003602 All individuals were childhood cancer survivors. Of the 6,414 childhood cancer survivors, 1,374 had received neck radiotherapy (neck-RT) as a form of treatment. Cases were individuals who developed subsequent thyroid cancer (STC). Cases of STC were ascertained by self-report questionnaires and subsequently confirmed by pathology reports. 73 of the 121 STC cases had received neck-RT as a form of childhood cancer treatment, whilst 48 had not. Of the controls, 1,301 had received neck-RT as a form of childhood cancer treatment. Median = 36.5 years
[
  • 121 cases
  • , 6,295 controls
]
,
47.7 % Male samples
European NR
PSS003603 All individuals were childhood cancer survivors. Of the 2,370 childhood cancer survivors, 476 had received neck radiotherapy (neck-RT) as a form of treatment. Cases were individuals who developed subsequent thyroid cancer (STC). Cases of STC were clinically ascertained. 47 of the 65 STC cases had received neck-RT as a form of childhood cancer treatment, whilst 18 had not. Median = 36.6 years
IQR = [30.3, 44.1] years
[
  • 65 cases
  • , 2,305 controls
]
,
53.4 % Male samples
European SJCRH